Contineum Therapeutics, Inc.
CTNM
$11.43
-$0.10-0.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.46M | -15.16M | -12.79M | -16.04M | -15.99M |
| Total Depreciation and Amortization | 83.00K | 85.00K | 81.00K | 79.00K | 78.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.05M | 2.76M | 2.81M | 2.23M | 2.58M |
| Change in Net Operating Assets | -5.95M | -731.00K | -2.29M | -1.93M | -1.08M |
| Cash from Operations | -16.27M | -13.04M | -12.20M | -15.66M | -14.41M |
| Capital Expenditure | -312.00K | -42.00K | -98.00K | -44.00K | -47.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.00M | -47.41M | 15.04M | 13.93M | 14.96M |
| Cash from Investing | -39.31M | -47.45M | 14.94M | 13.88M | 14.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 198.00K | 93.47M | 19.19M | 267.00K | 24.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -69.00K | 0.00 | -80.00K | -176.00K | -- |
| Cash from Financing | 129.00K | 93.47M | 19.11M | 91.00K | 24.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.45M | 32.97M | 21.85M | -1.69M | 527.00K |